Amrize Ltd (NYSE:AMRZ) Receives $60.50 Average PT from Brokerages

Shares of Amrize Ltd (NYSE:AMRZ) have been given an average recommendation of “Moderate Buy” by the fifteen brokerages that are covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $60.6667.

Several research firms have recently issued reports on AMRZ. Royal Bank Of Canada lowered Amrize from an “outperform” rating to a “sector perform” rating and upped their target price for the company from $56.00 to $60.00 in a report on Monday, December 8th. Kepler Capital Markets raised Amrize to a “strong-buy” rating in a research report on Tuesday, October 21st. Oddo Bhf began coverage on Amrize in a research note on Monday, November 3rd. They set a “neutral” rating on the stock. Stephens began coverage on Amrize in a report on Friday, November 14th. They set an “overweight” rating and a $60.00 price objective for the company. Finally, Wall Street Zen upgraded shares of Amrize to a “hold” rating in a research note on Saturday, October 25th.

Amrize Stock Performance

AMRZ opened at $54.52 on Thursday. The company has a current ratio of 1.45, a quick ratio of 0.97 and a debt-to-equity ratio of 0.38. Amrize has a 1-year low of $44.12 and a 1-year high of $58.11. The firm has a fifty day moving average of $53.17. The company has a market capitalization of $30.15 billion and a P/E ratio of 29.63.

Amrize (NYSE:AMRZ) last issued its earnings results on Wednesday, October 29th. The company reported $0.98 earnings per share for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.03). The firm had revenue of $3.68 billion during the quarter, compared to the consensus estimate of $3.49 billion. The company’s revenue for the quarter was up 6.6% compared to the same quarter last year.

Insider Buying and Selling

In other news, CTO Roald Brouwer bought 4,000 shares of the firm’s stock in a transaction that occurred on Friday, October 31st. The shares were bought at an average cost of $51.77 per share, with a total value of $207,080.00. Following the completion of the purchase, the chief technology officer directly owned 9,000 shares in the company, valued at $465,930. This represents a 80.00% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, Director Nicholas C. Gangestad purchased 2,000 shares of the stock in a transaction that occurred on Wednesday, November 19th. The shares were purchased at an average price of $47.34 per share, with a total value of $94,680.00. Following the completion of the acquisition, the director directly owned 4,958 shares in the company, valued at $234,711.72. The trade was a 67.61% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders bought a total of 65,000 shares of company stock valued at $3,399,720 over the last three months.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its stake in shares of Amrize by 41.0% during the 3rd quarter. Vanguard Group Inc. now owns 30,094,083 shares of the company’s stock valued at $1,468,460,000 after purchasing an additional 8,743,543 shares in the last quarter. Norges Bank bought a new position in shares of Amrize in the 2nd quarter worth about $670,915,000. Dodge & Cox bought a new position in shares of Amrize during the second quarter valued at approximately $622,085,000. Wellington Management Group LLP increased its position in Amrize by 48.8% during the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock valued at $561,018,000 after buying an additional 3,809,133 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Amrize by 4.6% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,518,018 shares of the company’s stock worth $459,242,000 after purchasing an additional 420,728 shares in the last quarter.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.